CA1012061A - Oral contraceptive regimens and packaged unit dosage forms thereof - Google Patents

Oral contraceptive regimens and packaged unit dosage forms thereof

Info

Publication number
CA1012061A
CA1012061A CA167,941A CA167941A CA1012061A CA 1012061 A CA1012061 A CA 1012061A CA 167941 A CA167941 A CA 167941A CA 1012061 A CA1012061 A CA 1012061A
Authority
CA
Canada
Prior art keywords
dosage forms
unit dosage
packaged unit
oral contraceptive
contraceptive regimens
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA167,941A
Other languages
English (en)
Other versions
CA167941S (en
Inventor
Eugene J. Segre
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Palo Alto LLC
Original Assignee
Roche Palo Alto LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Palo Alto LLC filed Critical Roche Palo Alto LLC
Application granted granted Critical
Publication of CA1012061A publication Critical patent/CA1012061A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
CA167,941A 1972-04-24 1973-04-04 Oral contraceptive regimens and packaged unit dosage forms thereof Expired CA1012061A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24701272A 1972-04-24 1972-04-24
US05/250,785 US3932635A (en) 1972-04-24 1972-05-05 Novel cyclic progestogen-interrupted estrogen oral contraceptive regimens

Publications (1)

Publication Number Publication Date
CA1012061A true CA1012061A (en) 1977-06-14

Family

ID=26938396

Family Applications (1)

Application Number Title Priority Date Filing Date
CA167,941A Expired CA1012061A (en) 1972-04-24 1973-04-04 Oral contraceptive regimens and packaged unit dosage forms thereof

Country Status (9)

Country Link
US (1) US3932635A (fr)
BE (1) BE798585A (fr)
CA (1) CA1012061A (fr)
FR (1) FR2182992B1 (fr)
GB (1) GB1384214A (fr)
HK (1) HK27276A (fr)
MY (1) MY7600093A (fr)
NL (1) NL169681C (fr)
NZ (1) NZ170401A (fr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4145416A (en) * 1976-06-23 1979-03-20 Schering, A.G. Novel agents and novel methods for treatment of climacteric disturbances
DE3029726A1 (de) * 1980-08-06 1982-02-25 Werner Dr.med. 4400 Münster Steinschulte Postkoitale kontrazeptiva mit norgestrel oder levonorgestrel
US4425339A (en) 1981-04-09 1984-01-10 Syntex (U.S.A.) Inc. Treatment of menopausal symptoms
US5010070A (en) * 1987-06-15 1991-04-23 Warner-Lambert Company Graduated estrogen contraceptive
US5208225A (en) * 1986-02-27 1993-05-04 Warner-Lambert Company Compositions containing fixed combinations
US4762717A (en) * 1986-03-21 1988-08-09 The General Hospital Corporation Continuous delivery of luteinizing hormone releasing hormone compositions in combination with sex steroid delivery for use as a contraceptive
US5276022A (en) * 1987-09-24 1994-01-04 Jencap Research Ltd. Hormone preparation and method
US5108995A (en) * 1987-09-24 1992-04-28 Jencap Research Ltd. Hormone preparation and method
GB2217988B (en) * 1988-04-11 1992-04-01 Gould Leonard W Regimen for increasing bone density in humans
EP0368373A1 (fr) * 1988-10-13 1990-05-16 Akzo Nobel N.V. Préparation contraceptive multiphase
US5116865A (en) * 1990-09-05 1992-05-26 Peters Richard H 15,16-seco-19-nor progestins
US5433219A (en) * 1992-09-23 1995-07-18 Spery; Nanette S. Receptive condom assembly
DE4344462C2 (de) 1993-12-22 1996-02-01 Schering Ag Zusammensetzung für die Empfängnisverhütung
US5552394A (en) * 1994-07-22 1996-09-03 The Medical College Of Hampton Roads Low dose oral contraceptives with less breakthrough bleeding and sustained efficacy
US6214815B1 (en) 1998-12-23 2001-04-10 Ortho-Mcneil Pharmaceuticals, Inc. Triphasic oral contraceptive
US7459445B2 (en) * 2000-03-10 2008-12-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and topical pharmaceutical formulations of the same
US6855703B1 (en) 2000-03-10 2005-02-15 Endeavor Pharmaceuticals Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds
US7989436B2 (en) 2003-07-23 2011-08-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and pharmaceutical formulations comprising the same
US6660726B2 (en) 2000-03-10 2003-12-09 Endeavor Pharmaceuticals Estrogenic compounds, pharmaceutical compositions thereof, and methods of using same
US7444305B2 (en) * 2001-02-15 2008-10-28 Mass Connections, Inc. Methods of coordinating products and service demonstrations
US20130203722A1 (en) * 2006-09-26 2013-08-08 Rhonda R. Voskuhl Estriol therapy for autoimmune and neurodegenerative disease and disorders
JP2004140323A (ja) * 2002-08-20 2004-05-13 Sharp Corp 半導体レーザ装置およびその製造方法
US6992075B2 (en) * 2003-04-04 2006-01-31 Barr Laboratories, Inc. C(14) estrogenic compounds
MXPA05010871A (es) * 2003-04-11 2005-11-25 Barr Lab Inc Metodos para administrar estrogenos y progestinas.
US20060057186A1 (en) * 2004-09-11 2006-03-16 Margaret Heller Oral contraceptive multivitamin compound and methods of administration
EP1853272A1 (fr) * 2005-02-03 2007-11-14 Duramed Pharmaceuticals, Inc. Compositions d'oestrogenes non conjugues et procedes destines a leur utilisation
WO2015168002A1 (fr) * 2014-04-28 2015-11-05 The Regents Of The University Of California Conditionnement pharmaceutique pour thérapie à l'estriol
US10799512B2 (en) 2014-04-28 2020-10-13 The Regents Of The University Of California Estrogen combination for treatment of multiple sclerosis
EP3188735A4 (fr) 2014-09-02 2018-01-24 The Regents of the University of California Thérapie oestrogénique pour traitement l'atrophie de la matière grise cérébrale et le handicap associé
WO2016160832A1 (fr) 2015-03-30 2016-10-06 The Regents Of The University Of California Méthodes de surveillance de thérapie à base d'œstriol

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3409721A (en) * 1967-09-15 1968-11-05 Neomed Lab Inc Oral dosage system effective to control the reproduction cycle
NL6903028A (fr) * 1969-02-26 1970-08-28
US3591688A (en) * 1969-08-22 1971-07-06 American Home Prod Method of preventing ovulation and composition therefor
US3660574A (en) * 1969-09-11 1972-05-02 Warner Lambert Co Method of controlling fertility employing quingestanol acetate
US3755573A (en) * 1970-07-10 1973-08-28 Warner Lambert Co Fertility control empoying quinestrol and quingestanol acetate

Also Published As

Publication number Publication date
US3932635A (en) 1976-01-13
NL169681C (nl) 1982-08-16
FR2182992A1 (fr) 1973-12-14
MY7600093A (en) 1976-12-31
DE2319850B2 (de) 1975-08-07
NZ170401A (en) 1978-07-28
AU5466473A (en) 1974-10-24
NL169681B (nl) 1982-03-16
BE798585A (fr) 1973-10-24
HK27276A (en) 1976-05-21
FR2182992B1 (fr) 1976-07-02
GB1384214A (en) 1975-02-19
DE2319850A1 (de) 1973-11-08
NL7305734A (fr) 1973-10-26

Similar Documents

Publication Publication Date Title
CA1012061A (en) Oral contraceptive regimens and packaged unit dosage forms thereof
CA1011205A (en) Intra-uterine contraceptive device
CA954835A (en) Portable and disposable dispensing packages
IL42232A0 (en) Dry medicines for oral administration
AU463937B2 (en) Oral contraceptives
CA976470A (en) Detachable tablet arm and bookrack
CA1036072A (fr) Compose pharmaceutique oral favorisant l'absorption
ZA733406B (en) Pharmaceutical formulations
IL42462A0 (en) Oral preparations
IE38280B1 (en) Pharmaceutical antimycotic compositions medicaments and method
CA1000708A (en) Phenobarbital salts and therapeutic compositions containing same
ZA735623B (en) Pharmaceutically active compounds and their preparation and compositions
PH11231A (en) Piperidinesulfonylurea derivatives and pharmaceutical compositions containing them
ZA734719B (en) Oral preparations
AU5731773A (en) 2-oxo-indoline compounds and pharmaceutical compositions
AU5512273A (en) Medicinal preparations for oral use
ZA732349B (en) Novel oral contraceptive regimens and packaged unit dosage forms thereof
GB1404424A (en) Thiocarboxamides and preparation thereof
ZA738187B (en) Pharmaceutical composition and preparation thereof
AU488352B2 (en) n NOVEL ORAL CONTRACEPTIVE REGIMENS AND PACKAGED UNIT DOSAGE FORMS THEREOF
AU464515B2 (en) Condensed bensopyran derivatives and pharmaceutical compositions containing them
PH10790A (en) Norbornane derivatives and pharmaceutical compositions containg same
AU4736172A (en) Filling and
KE2807A (en) Pharmaceutical formulations
AU6087773A (en) Octahydro-aryl-isoquinolines and derivatives thereof